Document is current
Any future updates will be listed below
-
Authors
Hotta, Kinichi http://orcid.org/0000-0001-5608-0968
Otake, Yosuke
Yamaguchi, Daisuke
Shimodate, Yuichi
Hanabata, Norihiro
Ikematsu, Hiroaki
Yabuuchi, Yohei
Sano, Yasushi
Shimoda, Ryo
Sugimoto, Shinya
Oba, Mari
Takamaru, Hiroyuki
Kimura, Kouichiro
Kishida, Yoshihiro
Takada, Kazunori
Ito, Sayo
Imai, Kenichiro
Hosotani, Kazuya
Murano, Tatsuro
Yamada, Masayoshi
Shinmura, Kensuke
Takezawa, Rio
Tomonaga, Michito
Saito, Yutaka
-
Funding
Funding for this research was provided by:
Nippon Chemiphar Co.Ltd.
- License Information
-
More Information
Article History
Received: 18 August 2023
Accepted: 23 January 2024
First Online: 3 February 2024
Declarations
:
: This trial was approved by the Certificated Review Board of Shizuoka Cancer Centre (CRB4180010) and submit an implementation plan to the MHLW. Then, the principal investigator must obtain approval from the administrator of the medical institution to conduct this clinical study. Written informed consent will be obtained from every study participants.
: Not applicable.
: The corresponding author (Kinichi Hotta) has received research funding from Nippon Chemiphar Co.Ltd. The other authors declare that they have no conflict of interest associated with this trial.
